1-9 of 9
N Ifrah
Close
Sort by
Journal Articles

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience.

C. Kelaidi, S. Chevret, S. de Botton, E. Raffoux, A. Guerci, X. Thomas, C. Gardin, A. Pigneux, A. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, S. Meyer-Monard, R. Chelo, T. Pabst, P. Chevalier, F. Maloisel, E. Deconinck, A. Ferrant, D. Bron, N. Fegueux, J. de la Serna, G. Martin, J. Cahn, N. Ifrah, B. Cassinat, H. Dombret, M.A. Sanz, Pierre Fenaux, L. Ades
Journal: Blood
Blood (2007) 110 (11): 1845.
https://doi.org/10.1182/blood.V110.11.1845.1845
Published: 2007
Journal Articles

No Benefit of Adding High-Dose Melphalan (HDM) Suppported by Autologous Stem Cell Transplantation (SCT) over Treatment with Conventional Induction, HD ARAC Consolidation, and Auto SCT (Busulfan + HDM) for Acute Myelogenous Leukemia (AML) under 60: First Results of the Randomized AML 2001 Trial.

B. Lioure, A. Pigneux, C. Recher, F. Witz, T. Lamy, N. Fegueux, C.E. Bulabois, N. Ifrah, I. Luquet, D. Bouscary, N. Vey, M. Delain, J.O. Bay, P. Turlure, Jean-Luc Harousseau
Journal: Blood
Blood (2006) 108 (11): 608.
https://doi.org/10.1182/blood.V108.11.608.608
Published: 2006
Journal Articles

Bortezomid-Induced Sweet Syndrome.

Aline A. Schmidt-Tanguy, MD, Martine M. Avenel-Audran, MD, Séverine S. Lissandre, MD, Mammoun M. Dib, MD, Anne A. Croue, MD, Marie-Pierre M.P. Moles, MD, Norbert N. Ifrah, MD PhD, Mathilde M. Hunault-Berger, MD PhD
Journal: Blood
Blood (2006) 108 (11): 5128.
https://doi.org/10.1182/blood.V108.11.5128.5128
Published: 2006
Journal Articles

Blockade of p110delta Isoform Activity of Phosphoinositide 3-Kinase Inhibits Blast Cell Proliferation in Acute Myeloblastic Leukemia.

D. Bouscary, MD-PhD, V. Bardet, MD, P. Sujobert, MD, P. Cornillet-Lefebvre, MD, J. S. Hayflick, PhD, N. Prie, MD, F. Verdier, PhD, B. Vanhaesebroeck, PhD, O. Muller, F. Pesce, MD, N. Ifrah, MD, M. Hunault Berger, MD-PhD, C. Bertho, MD-PhD, G. Guillerm, MD, B. Villemagne, MD, B. Audhui, MD, E. Solary, MD-PhD, F. Witz, MD, J. L. Harousseau, MD, C. Himberlin, MD, T. Lamy, MD-PhD, B. Lioure, MD, M. C. Bene, MD, J. Y. Cahn, MD, F. Dreyfus, MD, P. Mayeux, PhD, C. Lacombe, MD-PhD
Journal: Blood
Blood (2004) 104 (11): 2522.
https://doi.org/10.1182/blood.V104.11.2522.2522
Published: 2004
Journal Articles

Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study

E Solary, B Witz, D Caillot, P Moreau, B Desablens, JY Cahn, A Sadoun, B Pignon, C Berthou, F Maloisel, D Guyotat, P Casassus, N Ifrah, Y Lamy, B Audhuy, P Colombat, JL Harousseau
Journal: Blood
Blood (1996) 88 (4): 1198–1205.
https://doi.org/10.1182/blood.V88.4.1198.bloodjournal8841198
Published: 1996
Journal Articles

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

L Sutton, C Chastang, P Ribaud, JP Jouet, M Kuentz, M Attal, J Reiffers, JM Tigaud, B Rio, C Dauriac, M Legros, F Dreyfus, B Lioure, X Troussard, N Milpied, F Witz, P Oriol, JY Cahn, M Michallet, E Gluckman, N Ifrah, JL Pico, E Vilmer, V Leblond
Journal: Blood
Blood (1996) 88 (1): 358–365.
https://doi.org/10.1182/blood.V88.1.358.358
Published: 1996
Journal Articles

Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)

A Devergie, D Blaise, M Attal, JD Tigaud, JP Jouet, JP Vernant, P Bordigoni, N Ifrah, C Dauriac, JY Cahn
Journal: Blood
Blood (1995) 85 (8): 2263–2268.
https://doi.org/10.1182/blood.V85.8.2263.bloodjournal8582263
Published: 1995
Journal Articles

Double-intensive therapy in high-risk multiple myeloma

JL Harousseau, N Milpied, JP Laporte, P Collombat, T Facon, JD Tigaud, P Casassus, F Guilhot, N Ifrah, C Gandhour
Journal: Blood
Blood (1992) 79 (11): 2827–2833.
https://doi.org/10.1182/blood.V79.11.2827.2827
Published: 1992
Journal Articles

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, N Milpied, M Attal, M Michallet, N Ifrah
Journal: Blood
Blood (1992) 79 (10): 2578–2582.
https://doi.org/10.1182/blood.V79.10.2578.2578
Published: 1992